Bulevirtide is the only approved antiviral drug against hepatitis delta.
Regulatory
Actions of government agencies regulating the pharmaceutical industry: approval, rejection, and prohibition of drugs, granting special statuses.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Covovax/Nuvaxovid: Nanoparticle Vaccine for COVID-19
Covovax/Nuvaxovid by Novavax is a protein subunit vaccine from virus-like particles.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus
One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.
Posted inCOVID-19, Infections, New Drugs, Regulatory
Covifenz: Medicago’s Plant-Derived COVID-19 Vaccine
Innovative Medicago’s vaccine is made by molecular pharming technology.
Posted inInfections, New Drugs, Oncology, Regulatory
Talicia: Highly Effective Eradication Regimen for Helicobacter pylori
Combination drug invented by RedHill Biopharma will get rid of Helicobacter pylori infection in 90% of patients.
Posted inMetabolism, New Drugs, Regulatory
Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Posted inInfections, Regulatory
Voquezna: New Drug for Acid-Related Gastrointestinal Diseases
Vonoprazan for Helicobacter pylori eradication and for treating erosive esophagitis, non-erosive gastroesophageal reflux disease (NERD), and gastroesophageal reflux disease (GERD).